Endometrial Carcinoma — Niraparib Monotherapy as Maintain and Recurrent Treatment of Endometrial Serous Carcinoma
Citation(s)
Niraparib Monotherapy as Maintain and Recurrent Treatment of Endometrial Serous Carcinoma: A Multi-center, Open-label, Prospective Clinical Study